These final results, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two support the notion of concentrating on ACKR3 as a unique way to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-related disorders. So, prior to https://rachelj046mid5.bloguerosa.com/profile